TerminatedNot applicableNCT01987193
Feasibility Study of Tumor Blood Flow Measurement by Detection of Positron Activation Post Proton Therapy (DS01)
The purpose of this study is the development of noninvasive (having no direct contact) detector and electronic system that will directly measure tumor blood flow rate.
Checked against the public recordLast updated May 29, 2018 · Source: ClinicalTrials.gov
StatusTerminated
PhaseNot applicable
U.S. locations1
SponsorUniversity of Florida
Study overview
What this study is about
- Purpose
- Not specified
- Study type
- Observational
- Phase
- Not applicable
- Sponsor
- University of Florida
- Interventions being studied
- Not specified
Explore related studies
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Treatment approach
Public criteria
Who may be able to participate
Inclusion Criteria: Solid tumors in the intracranial, thoracic, or pelvic regions. Exclusion Criteria: N/A \-
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
Study sites
U.S. locations
- University of Florida Proton Therapy InstituteJacksonville, Florida
Source and freshness
Processed from ClinicalTrials.gov. Last public update: May 29, 2018. Always confirm current availability with the study team.